Kelly Kemp, PhD ViaCyte

Kelly Kemp, PhD is the Director of Process Development at ViaCyte, working to characterize and optimize the manufacturing process of an innovative stem cell derived product aiming to treate diabetes. With a passion for biology and technology, as well as a proficient understanding of GMP and regulatory requirements, Kelly has had a strong career focus on scaling-up cell production processes and implementing process improvements.

Kelly earned her Ph.D. in Developmental Biology from the Free University of Brussels, Belgium and continued her training, as a postdoctoral fellow at the Salk Institute for Biological Studies in La Jolla, CA, focusing on the transcriptional regulation of human pluripotent stem cells. Kelly has led process development teams for cell-based products at Shire, Stemedica Cell Technologies, and Vital Therapies.